ALPS Medical Breakthrough... (SBIO)
AMEX: SBIO
· Real-Time Price · USD
34.85
-0.20 (-0.56%)
At close: Aug 18, 2025, 3:59 PM
35.26
1.18%
After-hours: Aug 18, 2025, 07:45 PM EDT
-0.56% (1D)
| Bid | 26.06 |
| Market Cap | 76.41M |
| AUM | 77.06M |
| NAV | 32.79 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 2.19M |
| Inception Date | Dec 30, 2014 |
| Ask | 40 |
| Volume | 7.68K |
| Open | 35.41 |
| Previous Close | 35.05 |
| Day's Range | 34.85 - 35.41 |
| 52-Week Range | 22.33 - 42.73 |
| Holdings | 103 |
| Expense Ratio | 0.50% |
About SBIO
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Asset Class Equity
Ticker Symbol SBIO
Inception Date Dec 30, 2014
Provider SS&C
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 29.25% of assets
| Name | Symbol | Weight |
|---|---|---|
| Rhythm Pharmaceutica... | RYTM | 3.71% |
| Avidity Biosciences,... | RNA | 3.43% |
| Axsome Therapeutics,... | AXSM | 3.17% |
| Nuvalent, Inc. | NUVL | 3.08% |
| Merus N.v. | MRUS | 2.98% |
| Alkermes Plc | ALKS | 2.71% |
| Viking Therapeutics,... | VKTX | 2.67% |
| Acadia Pharmaceutica... | ACAD | 2.58% |
| Cytokinetics, Incorp... | CYTK | 2.46% |
| Krystal Biotech, Inc... | KRYS | 2.46% |
Dividends Dividend Yield 3.52%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 19, 2024 | $1.1740 | Dec 26, 2024 |
| Dec 21, 2023 | $0.0711 | Dec 27, 2023 |
| Dec 19, 2019 | $0.0158 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 21, 2017 | $0.5795 | Dec 28, 2017 |
